CD44 and CD133 protein expression might serve as a prognostic factor for early occurrence castration-resistant prostate cancer.

Yayi DwinaLitta Septina Mahmelia ZaidMeilania SaraswatiLisnawati RachmadiAria KekalihNur RahadianiMelva LouisaHasrayati AgustinaChaidir Arif MochtarAgus Rizal Ardy Hariandy Hamid

Published in: The Prostate (2024)

This study found a low expression of at least one CD44/CD133 protein in the patients without early occurrence of CRPC. This result might suggest that CD44/CD133 may function as a potential prognostic marker for PCa, especially in a low expression, to identify patients who have a better prognosis regarding the occurrence of early CRPC.

Keyphrases

prognostic factors
end stage renal disease
risk assessment
newly diagnosed
chronic kidney disease
poor prognosis
ejection fraction
long non coding rna
climate change
protein protein
nk cells